Sargachromenol Attenuates Inflammatory Responses by Regulating NF-κB and Nrf2 Pathways in RAW 264.7 Cells and LPS-treated Mice
Planta Medica · 01.01.2024 · 90 (01) · 25-37
DOI: 10.1055/a-2180-1338 ↗Kurz gefasst
Fachartikel in der Zeitschrift Planta Medica, erschienen am 01.01.2024. Verfasst von Eun-Ji Joung und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Food Science and Nutrition, Pukyong National University, Busan, Republic of Korea. Hauptthemen laut MEDLINE: NF-kappa B, Lipopolysaccharides. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: Korea Institute of Marine Science and Technology promotion, National Research Foundation of Korea, Korea Coast Guard.
Abstract (Originalsprache)
This study aims to explore the anti-inflammatory mechanisms of sargachromenol in both RAW 264.7 cells and lipopolysaccharide (LPS)-treated mice, as previous reports have suggested that sargachromenol possesses anti-aging, anti-inflammatory, antioxidant, and neuroprotective properties. Although the precise mechanism behind its anti-inflammatory activity remains unclear, pretreatment with sargachromenol effectively reduced the production of nitric oxide, prostaglandin E2, and interleukin (IL)-1β in LPS-stimulated RAW 264.7 cells by inhibiting cyclooxygenase-2. Moreover, sargachromenol inhibited the activation of nuclear factor-κB (NF-κB) by preventing the degradation of the inhibitor of κB-α (IκB-α) and inhibiting protein kinase B (Akt) phosphorylation in LPS-stimulated cells. We also found that sargachromenol induced the production of heme oxygenase-1 (HO-1) by activating the nuclear transcription factor erythroid-2-related factor 2 (Nrf2). In LPS-treated mice, oral administration of sargachromenol effectively reduced the levels of IL-1β, IL-6, and tumor necrosis factor-α (TNF-α) in the serum, suggesting its ability to suppress the production of inflammatory mediators by inhibiting the Akt/NF-κB pathway and upregulating the Nrf2/HO-1 pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Food Science and Nutrition, Pukyong National University, Busan, Republic of Korea.
- Department of Molecular and Cellular Physiology, Louisiana State University Health Shreveport, Louisiana, United States.
- Division of Food and Nutrition, Chonnam National University, Gwangju, Republic of Korea.
- Department of Smart Green Technology Engineering, Pukyong National University, Busan, Republic of Korea.
- Division of Biomedical Engineering and Research Center for Marine Integrated Bionics Technology, Pukyong National University, Busan, Republic of Korea.
ORCID-Profile: Bonggi Lee
Förderung
- Korea Institute of Marine Science and Technology promotion
- National Research Foundation of Korea
- Korea Coast Guard
Zitieren
APA
Joung, E. J., Lee, M. K., Lee, M., Gwon, M., Shin, T., Ryu, H., Jeong, H. H., Kim, M. J., Van, J. Y., Kim, J. I., Choi, J., Jung, W. K., Kim, H. R., & Lee, B. (2024). Sargachromenol Attenuates Inflammatory Responses by Regulating NF-κB and Nrf2 Pathways in RAW 264.7 Cells and LPS-treated Mice. Planta Medica, 90(01), 25-37. https://doi.org/10.1055/a-2180-1338
Vancouver
Joung EJ, Lee MK, Lee M, Gwon M, Shin T, Ryu H, et al. Sargachromenol Attenuates Inflammatory Responses by Regulating NF-κB and Nrf2 Pathways in RAW 264.7 Cells and LPS-treated Mice. Planta Medica. 2024;90(01):25-37. doi:10.1055/a-2180-1338
BibTeX
@article{Joung2024,
author = {Joung, Eun-Ji and Lee, Min-Kyeong and Lee, Minsup and Gwon, Misung and Shin, Taisun and Ryu, Heeyeon and Jeong, Hyeon Hak and Kim, Myeong-Jin and Van, Ji Yun and Kim, Jae-Il and Choi, Jinkyung and Jung, Won-Kyo and Kim, Hyeung-Rak and Lee, Bonggi},
title = {Sargachromenol Attenuates Inflammatory Responses by Regulating NF-κB and Nrf2 Pathways in RAW 264.7 Cells and LPS-treated Mice},
journal = {Planta Medica},
year = {2024},
volume = {90},
number = {01},
pages = {25--37},
doi = {10.1055/a-2180-1338}
}
EUVIMED